Market Overview

Global Market for In Vitro Toxicity Testing Hits $6.4 Billion in 2018, Report


Global Market for In Vitro Toxicity Testing Hits $6.4 Billion in 2018, Report

PR Newswire

ROCKVILLE, Md., July 24, 2018 /PRNewswire/ -- The global market for in vitro toxicity testing is estimated to be $6.4 billion in 2018, according to Kalorama Information. The in vitro toxicity testing markets include methods and technologies used for toxicity testing of pharmaceuticals, cosmetics, chemicals and food ingredients based on biochemical, cellular and tissue-based assays and platforms. Major stake holders of this market include technology platform developers, reagents and labware suppliers, service providers and end-use industry segments that need to comply with regulatory safety data requirements. The healthcare market research firm's recent report, In Vitro Toxicology Market, examines global in vitro toxicity testing markets, regional market segments and industry segments.

Kalorama Information Logo.

"Reducing animal-based toxicity testing is becoming a possibility as public and private funding investments focus on the development of robust in vitro platforms," said Bruce Carlson, Publisher of Kalorama Information. "In Europe in particular there is a rising awareness about animal testing and commitment of regulatory agencies to promote alternative testing methods wherever possible."

Market Drivers

In addition to regulatory bans on animal testing on cosmetics in many countries and the rising government and regulatory agency focus leading to large scale funding for initiatives to promote non-animal testing for toxicity assessment, another factor that is expected to drive this market is the increasing focus of pharmaceutical companies on early toxicity testing.

The Market by Technology and Method

A major factor that has enabled the growth of the in vitro toxicity testing market is the advancement of various technologies such as cell culture technologies, high throughput technologies, cellular imaging technologies, and toxicogenomics. The advancement in 3D cell culture technologies, which are replacing 2D cell culture technologies, offer an opportunity to develop complex models that are better able to mimic in vivo systems.

Cellular and organotypic models and assays are accounting for a large share of the in vitro toxicity market as their ability to predict toxic effects in vivo is improving with technology advancements. Emerging market segments based on various methods for in vitro toxicity testing can be broadly classified into biochemical assays, cell-based assays and ex vivo systems.

Significant innovation is happening in the 3D cell culture-based method segment, which can influence the market landscape of in vitro toxicity testing.

The Market by Products and Services

The products and services segments within in vitro toxicity testing markets can be broadly segmented into various assays, services and reagents and labware. In Vitro Toxicology analyses the growth trends within each of these segments and estimates their market sizing in global and regional markets:

  • Global In Vitro Toxicity Testing Market, by Products and Services (2018-2023) (Assays, Services, Reagents & Labware, Total)
  • Markets for Various Assays for In Vitro Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for Reagents and Labware for In Vitro Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Toxicity Testing Services, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)

The Competitive Landscape

In Vitro Toxicology identifies major stakeholders and analyses their business strategies with respect to the market segments in which they are active. The study also profiles many leading and niche players of the market, including Charles River Laboratories (CRL), Eurofins Scientific and Thermo Fisher. The report can be found at:

About Kalorama Information

Kalorama Information, a division of, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on and

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website:   

Press Contact:
Bruce Carlson
212 807 2262


Cision View original content with multimedia:

SOURCE Kalorama Information

View Comments and Join the Discussion!